Sign in

neurooncologyhd.bsky.social

@neurooncologyhd.bsky.social
255 followers 245 following 26 posts

Activities of the Neurooncology Community in Heidelberg

PostsRepliesMedia
Reposted by @neurooncologyhd.bsky.social
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 3h
Join us for the #ICOM/BIMS sessions at #SBNS100 on Wednesday from 9:30-10:30. See the topics in the attached images, or on the event website: bit.ly/421mpCv
011
Reposted by @neurooncologyhd.bsky.social
Felix Ehret @felixehretmd.bsky.social · 05/10/2026
All roads lead to ROAM – but where do we go next? What does ROAM/EORTC-1308 mean for radiotherapy after complete resection of atypical meningioma? Read our Breaking News Editorial! @neuroonc.bsky.social @eanoassociation.bsky.social @astro-org.bsky.social doi.org/10.1093/neuo...
doi.org
All roads lead to ROAM: A look at the results of the ROAM/EORTC-1308 clinical trial
Felix Ehret, David R Raleigh; All roads lead to ROAM: A look at the results of the ROAM/EORTC-1308 clinical trial, Neuro-Oncology, , noag234, https://doi.o
021
Reposted by @neurooncologyhd.bsky.social
Alexander Pietras Lab @pietraslab.bsky.social · 24/09/2026
@elinnjohansson.bsky.social's latest paper is now online in Neuro-Oncology Pediatrics: ACVR1 mutations are shared by DMG and the bone disorder FOP, where hypoxia drives disease. Turns out hypoxia signaling is up in ACVR1-mutant pediatric gliomas too. Open access here: doi.org/10.1093/neup...
doi.org
Hypoxia signaling is elevated downstream of mutant ACVR1 in pediatric high-grade glioma
AbstractBackground. Pediatric diffuse midline gliomas (pDMG) are lethal tumors, with approximately 80% harboring a lysine-to-methionine mutation in histone
021
Reposted by @neurooncologyhd.bsky.social
EANO @eanoassociation.bsky.social · 20/09/2026
🎙️ Our special #EANO2026 series of Neuro-Oncology: The Podcast continues! Mihaela Lorger, Chair, & Matthijs van der Meulen, Next Chair of the EANO Educational Committee, join host Iris Verploegh to explore what participants can expect from this year’s Educational Day. 🎧 t1p.de/gayvh #NeuroOncology
034
Reposted by @neurooncologyhd.bsky.social
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 17/08/2026
The full article of ‘A #DeepLearning algorithm for fully automated volumetric measurement of #meningioma burden’ is now available in #NeuroOncology Advances: bit.ly/4qsK76c
012
Reposted by @neurooncologyhd.bsky.social
EANO @eanoassociation.bsky.social · 17/08/2026
Insights into professional well-being in neuro-oncology – recently published in Neuro-Oncology: Professional Grief, Burnout and Coping among Neuro-Oncologists: A Cross-Sectional Online Study (PROGRESS) The results will be presented at #EANO2026. 👉 pubmed.ncbi.nlm.nih.gov/42479169/ #EANOessentials
021
Reposted by @neurooncologyhd.bsky.social
Barbara Marte @barbmarte.bsky.social · 12/06/2026
new out in Nature this week www.nature.com/articles/s41...
nature.com
A prognostic human brain network for diffuse midline glioma - Nature
Tumour network mapping of diffuse midline glioma (DMG) defines a conserved and prognostically important brain network in children with DMG, consistent with the hypothesis that DMGs exploit otherw...
0113
Reposted by @neurooncologyhd.bsky.social
Deutsches Krebsforschungszentrum (DKFZ) @dkfz.bsky.social · 10/06/2026
Experts in Heidelberg have developed an AI system that can classify brain tumors with unprecedented accuracy using standard microscopic tissue sections. The system could accelerate the diagnosis of brain tumors worldwide. 🚀 t1p.de/fbfey
t1p.de
AI Diagnoses Brain Tumors in Minutes Instead of Weeks
Experts in Heidelberg have developed an AI system that can classify brain tumors with unprecedented accuracy using standard microscopic tissue sections. Using digitized standard stains, the system ide...
0103
Reposted by @neurooncologyhd.bsky.social
Areeba Patel @areebap.bsky.social · 10/06/2026
1/n Excited to share our new paper in Nature Cancer 🦀 Meet Hetairos (Greek- “companion”): an AI model that predicts >100 methylation-defined CNS tumour subtypes directly from a routine H&E slide 🧠 State of the art diagnostics- from the slide that’s already on every pathologists’ desk 🧵
386
Reposted by @neurooncologyhd.bsky.social
EANO @eanoassociation.bsky.social · 04/06/2026
👋 Students, Youngsters, Fellows, Postdocs, Nurses & AHP in #NeuroOncology! EANO invites you to register for the 21st Meeting of the European Association of Neuro-Oncology (#EANO2026) taking place from Sept 24-27, 2026 in Rome, IT. 👉 Register today! eano.eu/eano2026/reg... #btsm
033
Reposted by @neurooncologyhd.bsky.social
Roel Verhaak @roelverhaak.bsky.social · 04/06/2026
In our new collaborative paper on IDHmutant glioma with the Tirosh, Suva, Iavarone and Lasorella labs, we show how acquired genetic alterations converge with cell state changes and poor treatment responses. www.nature.com/articles/s41...
nature.com
Acquired genetic and cell-state changes in IDH-mutant glioma progression - Nature
Longitudinal transcriptomic, chromatin and genomic analyses of the two types of IDH-mutant glioma reveal in detail how disease progression is influenced by interdependent genetic, epigenetic and micro...
2167
Reposted by @neurooncologyhd.bsky.social
EANO @eanoassociation.bsky.social · 03/06/2026
‼️ Good news! Deadline for late-breaking abstract submission extended to June 09, 2026! Don't miss this opportunity to present your very latest reasearch breakthrough to the #NeuroOncology community at #EANO2026. Submit your abstract 👉 www.eano.eu/eano2025/abs... #btsm #braintumor
012
Reposted by @neurooncologyhd.bsky.social
EANO @eanoassociation.bsky.social · 26/05/2026
📣 It’s today! Registration for #EANO2026 is now open. Join us in #Rome (IT), Sept 24–27, 2026, and connect with leading experts in #NeuroOncology. 🎟 Early Bird fees available until July 7, 2026. 👉 eano.eu/eano2026/reg... #Neurosurgery #Neuroradiology #Neurology #Oncology #PalliativeCare #Nursing
043
Reposted by @neurooncologyhd.bsky.social
Giorgio Seano @giorgioseano.bsky.social · 26/05/2026
I am thrilled to co-organize the upcoming Paris Neuro-Oncology Conference (January 27-29, 2027), alongside an exceptional group of colleagues and brain tumor experts. Abstracts by Sept 18, 2026 Join us in Paris to discuss the latest frontiers in neuro-oncology. my.weezevent.com/paris-neuro-...
my.weezevent.com
Paris Neuro-Oncology Conference
The conference program will aim to highlight the constant evolution throughout life of the developmental, immune and neuronal contexts of brain tumors The thematic sessions will seek to establish lin...
051
Reposted by @neurooncologyhd.bsky.social
Cancer Neuroscience Heidelberg @cn-hd.bsky.social · 26/05/2026
📢 #CancerNeuroscience Online Seminar with @michellemonje.bsky.social from Stanford University, USA. Title: The Neuroscience of Brain Cancers June 16, from 5-6 PM CEST, please register here: us06web.zoom.us/meeting/regi...
052
Reposted by @neurooncologyhd.bsky.social
EANO @eanoassociation.bsky.social · 13/04/2026
🧪 𝗡𝗼𝘄 𝗼𝗽𝗲𝗻: #𝗘𝗔𝗡𝗢 𝗘𝗹𝗲𝗰𝘁𝗶𝗼𝗻𝘀 Be part of the Scientific Committee and help drive innovation and collaboration in the field. Submit your application by May 28, 2026 and get involved. Learn more 👉 www.eano.eu #NeuroOncology #braintumor #btsm
011
Reposted by @neurooncologyhd.bsky.social
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 10/04/2026
Read more about @gelarehzadeh.bsky.social research on ‘Decoding the #immunological landscape of #meningioma to identify new #treatment targets’ with the Brain Tumour Charity: bit.ly/4m8n7aa
011
Reposted by @neurooncologyhd.bsky.social
EANO @eanoassociation.bsky.social · 07/04/2026
💡 Recently published in "Cell Reports Medicine": TET CpG sequence-context-specific DNA demethylation shapes progression of IDH-mutant gliomas Open Access. Read more 🔗 t1p.de/wrciu @cellpress.bsky.social @angelodipa.bsky.social #EANOessentials #NeuroOncology #Oligodendrogliomas #OpenAccess
021
neurooncologyhd.bsky.social @neurooncologyhd.bsky.social · 02/04/2026
Congratulations!
010
Reposted by @neurooncologyhd.bsky.social
EANO @eanoassociation.bsky.social · 02/04/2026
🗳️ #EANO Elections 2026–2028 are open! Shape the future of neuro-oncology by joining the EANO Executive Board or one of our key committees. We invite motivated EANO members to apply and actively contribute to our community. 🗓 Deadline: May 28, 2026 💻 Apply via EventsAir 👉 t1p.de/EANO-Election
011
Reposted by @neurooncologyhd.bsky.social
Lena Kutscher @lenakutscher.bsky.social · 30/03/2026
New preprint alert! I'm excited to share our latest preprint where we investigate the underlying developmental causes of the male bias in the pediatric brain tumor Group 3/4 medulloblastoma. www.biorxiv.org/content/10.6...
graphical abstract for "Developmental determinants of male bias in medulloblastoma" preprint. We propose that boys are more likely to develop Group 3/4 medulloblastoma more vulnerable cells-of-origin are available for transformation. Specifically, GC_UBC progenitors in the developing cerebellum are more abundant in male murine embryos, as a result of testosterone exposure and the XY genotype.
1135
Reposted by @neurooncologyhd.bsky.social
EANO @eanoassociation.bsky.social · 30/03/2026
⏰ The clock is ticking! Only 3 days left to submit your abstract for #EANO2026 in Rome. Share your research, engage in meaningful discussions, and expand your professional network. We look forward to your contributions! Submit your abstract now! eano.eu/eano2026/#btsm
021
Reposted by @neurooncologyhd.bsky.social
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 31/03/2026
‘A microenvironment-determined risk continuum refines #subtyping in #meningioma and reveals determinants of #MachineLearning-based tumor classification’ is now out in Nature Genetics: go.nature.com/4v2Hlq1
021
Reposted by @neurooncologyhd.bsky.social
Luis J. Castro-Vega, MD, PhD @luiscastro-vega.bsky.social · 22/03/2026
www.nature.com/articles/s41...
nature.com
Modelling brain tumours with organoids: towards precision medicine in neuro-oncology - Nature Reviews Neurology
Organoids provide a useful model to capture the heterogeneity of brain tumours. Here, the authors assess current methodologies for generating organoids from various types of brain tumour and discuss h...
011
Reposted by @neurooncologyhd.bsky.social
EANO @eanoassociation.bsky.social · 19/03/2026
📚 Recently published in @cellpress.bsky.social – insights into #immunotherapy in #glioblastoma: Persistent T cell activation and cytotoxicity against glioblastoma following single oncolytic virus treatment in a clinical trial Full article: www.sciencedirect.com/science/arti... #EANOessentials
041
Reposted by @neurooncologyhd.bsky.social
EANO @eanoassociation.bsky.social · 14/03/2026
While the neuro-oncology community is gathering in Bucharest for inspiring #EANO events, the next highlight is already on the horizon. 🔬 Be part of #EANO2026 in Rome and present your research. Submit your abstract now: eano.eu/eano2026/abs... #NeuroOncology #BrainTumor #BTSM
023
Reposted by @neurooncologyhd.bsky.social
EANO @eanoassociation.bsky.social · 19/02/2026
Thank you to the many participants who joined the EANO–SNO Highlights Webinar 2025! Outstanding talks, engaging discussion, and key scientific insights from #EANO2025 & #SNO2025. 🎥 The full recording is now online on our YouTube channel – watch or rewatch anytime! 👉 youtu.be/REdE1Y8zQZQ?...
youtu.be
Webinar: 4th Annual SNO/EANO Highlights of 2025
YouTube video by EANO
122
Reposted by @neurooncologyhd.bsky.social
EANO @eanoassociation.bsky.social · 02/02/2026
Recently published in @cp-immunity.bsky.social: Spatial immune profiling defines a subset of human gliomas with functional tertiary lymphoid structures. 👉 Full article: www.cell.com/immunity/ful... #NeuroOncology #Glioma #OpenAccess #EANOessentials
011
Reposted by @neurooncologyhd.bsky.social
EANO @eanoassociation.bsky.social · 26/01/2026
Presented at #EANO2025 and published in Neuro Oncology: Associations of supramaximal resection with outcome in glioblastoma across age groups: a report of the RANO resect group by Philipp Karschnia et al 👉 Learn more: doi.org/10.1093/neuo... #RANO #glioblastoma #surgery #EANOessentials
doi.org
Associations of supramaximal resection with outcome in glioblastoma across age groups: A report of the RANO resect group
AbstractAbstract. BackgroundThe oncological role of resection in elderly patients with glioblastoma remains controversial. We evaluated the value of resect
052
Reposted by @neurooncologyhd.bsky.social
EANO @eanoassociation.bsky.social · 26/01/2026
𝙍𝙚𝙢𝙞𝙣𝙙𝙚𝙧: 𝙍𝙚𝙜𝙞𝙨𝙩𝙚𝙧 𝙛𝙤𝙧 𝙩𝙝𝙚 𝙀𝘼𝙉𝙊 𝙏𝙪𝙢𝙤𝙧 𝘽𝙤𝙖𝙧𝙙 𝟐𝟎𝟐𝟔 Following the successful first edition in Prague, the 2nd #EANOTumorBoard will take place on March 12, 2026, in Bucharest, RO, just before the #EANO Seminars. 🗓️ Registration deadline: February 23, 2026 www.eano.eu/eanomeetings...
024
Reposted by @neurooncologyhd.bsky.social
Deutsches Krebsforschungszentrum (DKFZ) @dkfz.bsky.social · 21/01/2026
Daniel Kirschenbaum from the DKFZ is developing new methods to find out how immune cells are suppressed by malignant brain tumors. He is being supported in this by the EACR-Mark Foundation & the Pezcoller Foundation with the highly endowed Rising Star Award. @d-kirschenbaum.bsky.social t1p.de/zibl3
t1p.de
Highly endowed research award for DKFZ scientist
Daniel Kirschenbaum from the German Cancer Research Center (DKFZ) is developing new methods to find out exactly how immune cells are suppressed by malignant brain tumors. He is being supported in this...
061
Reposted by @neurooncologyhd.bsky.social
EANO @eanoassociation.bsky.social · 21/01/2026
First presented at #EANO2024, this work has now been published in Neuro-Oncology. 👉 academic.oup.com/neuro-oncolo... #NeuroOncology #EANO #Glioma #ResearchHighlights #EANOessentials @lukasbunse.bsky.social @venkataramanilab.bsky.social @wickwolfgang.bsky.social @michael-platten.bsky.social
academic.oup.com
Multimodality mapping of immunotherapy distribution as a predictive marker in glioma
AbstractBackground. Scarce T cell infiltration, immunosuppressive tumor-associated macrophages and ineffective drug delivery drive glioma progression and l
031
Reposted by @neurooncologyhd.bsky.social
Winkler Laboratory @winklerlab.bsky.social · 20/01/2026
Coming soon: The #BrainConference on #CancerNeuroscience: 🗺️ Rungstedgaard (CPH,DM) 📅 25-28 Aug 2026 Please join chairs @michellemonje.bsky.social & Frank Winkler and an great line up of speakers to discuss the newest findings. Early bird registration is now open 👇 @fens.org #FENS #Neuroscience
fens.org
The Brain Conference on CANCER NEUROSCIENCE - Federation of European Neuroscience Societies
041
Reposted by @neurooncologyhd.bsky.social
EANO @eanoassociation.bsky.social · 19/01/2026
📣 Join the 4th Annual EANO/SNO Highlights Webinar Top abstracts from #EANO2025 (Prague) & #SNO2025 (Honolulu) – latest advances in neuro-oncology. 🗓 Feb 6, 2026 | ⏰ 18:30–19:30 CET 🎟 Free for #EANO & #SNO members 👉 Register now: bit.ly/EANO-SNO-2025 #NeuroOncology @neuroonc.bsky.social
022
Reposted by @neurooncologyhd.bsky.social
EANO @eanoassociation.bsky.social · 23/12/2025
#EANO2025 in Prague 🇨🇿 – the highlights. One of our most successful meetings yet: record abstracts, outstanding multidisciplinary science, strong early-career engagement, and for the first time patient representatives. #NeuroOncology. 🎥 youtu.be/CWuMWef_mmI See you in Rome for #EANO2026 🇮🇹
youtu.be
EANO Meeting 2025 in Prague
YouTube video by EANO
044
Reposted by @neurooncologyhd.bsky.social
Alexander Pietras Lab @pietraslab.bsky.social · 22/12/2025
📣 PREPRINT ALERT! Glioblastoma (GBM) often responds to radiotherapy, yet almost always recurs, frequently within high-dose radiation fields. www.biorxiv.org/content/10.6...
biorxiv.org
Coevolution of neoplastic and non-neoplastic reactive astrocyte states converges on mesenchymal-like and injury-response programs during murine glioblastoma progression and post-radiotherapy recurrenc...
Glioblastomas initially respond to radiotherapy but invariably recur, often within high-dose radiation treatment fields. Although stromal radiation responses are incompletely understood, evidence sugg...
192
Reposted by @neurooncologyhd.bsky.social
Winkler Laboratory @winklerlab.bsky.social · 05/12/2025
Now online: the @brainprize.org #webinars on #cancerneuroscience! 🧠🔬 Learn more about the #neuroscience of #braincancer, #cancer remodelling of #neuralcircuits, and #PNS #nerve regulation of #cancer from experts in the field! 👇 Enjoy!
brainprize.org
The Brain Prize webinar series 2025
Watch The Brain Prize webinars on Cancer Neuroscience featuring leading experts sharing advanced research on cancer–nervous system interactions.
052
Reposted by @neurooncologyhd.bsky.social
EANO @eanoassociation.bsky.social · 03/12/2025
📣 EANO Seminars 2026 – one week left to apply! The next #EANO seminars will take place in Bucharest, Romania, on March 13–14, 2026. 🗓️ Application deadline: December 10, 2025 👉 Learn more and apply today: www.eano.eu/eanoseminars... #EANO #EANO2026 #NeuroOncology #BrainTumour #CNS
052
Reposted by @neurooncologyhd.bsky.social
Felix Ehret @felixehretmd.bsky.social · 28/11/2025
What’s the role of the extent of resection in grade 2 IDH-mutant glioma? I’m delighted to see this work published in @thelancetoncol.bsky.social — thanks and congratulations to the team! @neuroonc.bsky.social @eanoassociation.bsky.social www.thelancet.com/journals/lan...
thelancet.com
A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group
The proposed RANO classification for extent of resection could serve as a tool for prognostic stratification. Although associations between survival and extensive surgery are evident sooner in patient...
051
neurooncologyhd.bsky.social @neurooncologyhd.bsky.social · 27/11/2025
Herzlichen Glückwunsch!
010
Reposted by @neurooncologyhd.bsky.social
Deutsche Forschungsgemeinschaft @dfg.de · 27/11/2025
Im Nachgang zum Webinar "DFG-Förderung für #ClinicianScientists" (6. November 2025, >280 Teilnehmer*innen) 👇 haben wir alle Informationen und auch die Präsentationsfolien auf unserer Website zusammengestellt - jetzt unter: ➡️ www.dfg.de/de/foerderun...
062
Reposted by @neurooncologyhd.bsky.social
Shwetal Mehta @shwetalm.bsky.social · 26/11/2025
So excited to share @ivycenter.bsky.social’s publication on early phase clinical trial evaluating safety, feasibility and biological readouts of 5-ALA sonodynamic therapy (SDT) in recurrent high grade glioma patients. www.science.org/doi/10.1126/... @nadersanai.bsky.social @anchitien.bsky.social
science.org
An early clinical trial of 5-ALA sonodynamic therapy in recurrent high-grade glioma
An early clinical study demonstrates feasibility of noninvasive 5-ALA sonodynamic treatment in nine patients with recurrent high-grade glioma.
151
Reposted by @neurooncologyhd.bsky.social
The Brain Prize @brainprize.org · 25/11/2025
Neurons help gliomas grow. Discover how in the first #BrainPrize2025 webinar with @michellemonje.bsky.social and Frank Winkler - pioneering insights reshaping brain cancer research. #braincancer #neuroscience #webinar youtu.be/k6Pgbq5IZGI?...
youtu.be
The Neuroscience of Brain Cancers
YouTube video by BrainPrize
0115
Reposted by @neurooncologyhd.bsky.social
EANO @eanoassociation.bsky.social · 26/11/2025
🧠 Thank you for joining us at the recent #EANOYoungsters Journal Club session: Lighting up PET imaging in IDH mutant gliomas 👉 Missed the latest session? No worries – you can catch up by watching the recording on YouTube: youtu.be/0i9XVEjDs5c?... We look forward to seeing you at our next session!
033
Reposted by @neurooncologyhd.bsky.social
Deutsche Forschungsgemeinschaft @dfg.de · 26/11/2025
#Prospects for #ECR: Join our online talk on 11 December! Our Team Research Careers provides an overview of all DFG funding instruments and gives advice on how to prepare your proposal for the review process. The meeting link will be published shortly before start here: sohub.io/e2ad
Logo of "Prospects", the DFG Research Career Series, calendar entries:
Thursday, 11 December 2025, 4-5:30 p.m. CET in English
01910
Reposted by @neurooncologyhd.bsky.social
Anna Golebiewska @annagolebiewska.bsky.social · 23/11/2025
Happy to share a new #NORLUX study on how humanized patient-derived xenografts of #glioblastoma can be useful in investigating immunosuppression and clinically-relevant immunotherapy testing. See for more: www.biorxiv.org/content/10.1... #immunotherapy, #preclinicalmodeling,
0154
Reposted by @neurooncologyhd.bsky.social
Winkler Laboratory @winklerlab.bsky.social · 21/11/2025
📢 Registration (free!) for the NCI webinar series 'Fueling Cancer Progression by the Nervous System' is open! 🧠🔬 Amongst many excellent speakers, Frank Winkler and @venkatesh-lab.bsky.social discuss #cancerneuroscience of #brainmetastasis 📅 6 exciting topics are covered by leaders in the field 💡!
events.cancer.gov
Fueling Cancer Progression by the Nervous System (Overview) | Events Registration
OverviewThe Fueling Cancer Progression by the Nervous System series will feature six webinars, each exploring the junction between neuroscience and cancer biology to advance our understanding of cance...
066
Reposted by @neurooncologyhd.bsky.social
EANO @eanoassociation.bsky.social · 20/11/2025
Are you a physician, nurse, researcher, technician, or allied health professional with an interest in #NeuroOncology? Join the next #EANO Seminars, taking place in Bucharest, RO, on March 13–14, 2026! - Application deadline: December 10, 2025 - Learn more & apply here: 👉 www.eano.eu/eanoseminars...
042
Reposted by @neurooncologyhd.bsky.social
EANO @eanoassociation.bsky.social · 13/11/2025
🧠 Thank you for joining us! The #EANOYoungsters #JournalClub on “Lighting up PET imaging in IDH mutant gliomas” brought together colleagues worldwide for a vibrant exchange on cutting-edge #NeuroOncology research. ▶️ Missed it? The recording will be available soon: www.youtube.com/@eano_associ...
042
Reposted by @neurooncologyhd.bsky.social
EANO @eanoassociation.bsky.social · 12/11/2025
Outstanding oral presentation at #EANO2025 in Prague, now published in #NeuroOncology: the Multicenter Randomized Phase II Study of R-MPV-A #Chemoimmunotherapy With or Without Low-Dose Whole-Brain #Radiotherapy for Newly-Diagnosed Primary... by Antonio Omuro & colleagues. 👉 doi.org/10.1093/neuo...
074